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Background: Brain ischemia initiates several metabolic events leading to neuronal death. These events mediate
large amount of damage that arises after some neurodegenerative disorders as well as transient brain ischemia.
Melissa officinalis is considered as a helpful herbal plant in the prevention of various neurological diseases like
Alzheimer that is related with oxidative stress.
Methods: We examined the effect of Melissa officinalis on hypoxia induced neuronal death in a cortical neuronal
culture system as in vitro model and transient hippocampal ischemia as in vivo model. Transient hippocampal
ischemia was induced in male rats by tow vessel-occlusion for 20 min. After reperfusion, the histopathological
changes and the levels inflammation, oxidative stress status, and caspase-3 activity in hippocampus were measured.
Results: Cytotoxicity assays showed a significant protection of a 10 μg/ml dose of Melissa against hypoxia in
cultured neurons which was confirmed by a conventional staining (P<0.05). Melissa treatment decrease caspase3
activity (P<0.05) and TUNEL-positive cells significantly (P<0.01). Melissa oil has also inhibited malon dialdehyde level
and attenuated decrease of Antioxidant Capacity in the hippocampus. Pro-inflammatory cytokines TNF-α, IL-1β
and HIF-1α mRNA levels were highly increased after ischemia and treatment with Melissa significantly suppressed
HIF-1α gene expression (P<0.05).
Discussion: Results showed that Melissa officinalis could be considered as a protective agent in various neurological
diseases associated with ischemic brain injury.
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Ischemic brain injury often causes irreversible neural dam-
age. The cascade of events leading to neuronal injury and
death in ischemia includes excitotoxicity, inflammation,
edema, apoptosis, and necrosis [1]. In humans and experi-
mental animals subjected to ischemia, selective and delayed
neuronal death occurs in pyramidal neurons of the hippo-
campal CA1 region [2]. Several studies have indicated that
early and late neuronal death occurring in the neurons of
cortex and hippocampus after ischemia could be both* Correspondence: hassanzadeh@tums.ac.ir
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reproduction in any medium, provided the orapoptotic and necrotic cell death [3]. A special kind of cell
death occurs some days after the initial ischemic insult, a
phenomenon termed delayed neuronal death (DND) [4].
It is demonstrated that hypoxia-inducible factor-1α
(HIF-1α), interleukin-1 β (IL-1β) and tumor necrosis fac-
tor α (TNF-α) expression increase in the rat brain dur-
ing cerebral ischemia induced by different models of
ischemia. In ischemic neuronal damage, inflammatory
responses involving cytokines, adhesion molecules and
leukocytes, are critical to the pathogenesis of tissue dam-
age [5]. Local inflammatory responses contribute to sec-
ondary injury to potentially viable tissues could lead to
clinical outcome in patients with ischemic stroke [6].
Reactive oxygen species (ROS) are a class of highly
reactive molecules derived from oxygen and generatedtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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duction of ROS and the subsequent oxidative stress
have been thought to play a pivotal role in ischemia/
reperfusion induced neuronal death.
Natural antioxidants in plants are well known to protect
human against free radicals and prevent from some dis-
eases. Melissa officinalis or Lemon balm, an herb from
the Labiatae family has traditionally been used for its
effects on nervous system. Melissa officinalis leaves con-
tain polyphenoliccompounds, such as rosmaric acid,
trimeric compounds and some flavonoids [8] that can
scavenge free radicals and have antioxidant properties [9].
This may prevent apoptosis induced by oxidative stress.
Essential oils derived from herbs have strong antioxidant
activity due to their high contents of phenolic compounds
and tocopherols [10]. Balm oil anti-diabetic and antioxi-
dant activity reported earlier [11]. It was reported that
some component of essential oil obtained from Melissia
officinalis such as monoterpene aldehydes, ketones (neral/
geranial, citronellal, isomenthone, and menthone) and
mono- and sesquiterpene hydrocarbons (E-caryophyllene)
poses free radical scavengering properties [10].
Neuroprotective effect of this plant was investigated
earlier by using an in vitro cellular model with PC12 cell
line, which was a hydrogen peroxide induced toxicity
system [7]. We have reported earlier that aqueous
extract of Melissa can provide neuroprotection against
ecstasy induced neurotoxicity in hippocampal primary
culture [12]. Recently it has been reported that oral
administration of Melissa officinalis can increase cell
proliferation and differentiation by decreasing serum
corticosterone levels as well as by increasing GABA
levels in the mouse dentate gyrus [13]. Infusion of lemon
balm (Melissa officinalis) leaf for 30 days in radiology
staffs exposed to low-dose ionizing radiation (x-ray) can
improve oxidative stress condition and DNA damage [9].
Although several reports have been published on
Melissa officinalis, there is no reported information, to
our knowledge, regarding the in vivo neuroprotection
properties of this plant. Studies on neurological and neu-
roprotective properties of Melissa officinalis may dem-
onstrate the effects of this plant on the central nervous
system as well as to elucidate the mechanisms involved
in the activity.
The present study was carried out to examine the pro-
tective effect of Melissa in an in vitro hypoxia model and
also the protective ability of administration before and
after ischemia followed by reperfusion in hippocampal
neurons as an in vivo model.
Methods
Cell culturing and treatment
Primary neuronal cultures were prepared from gestation
day 15 ⁄ 16 mouse embryos (Balb c) and cultured asdescribed previously [14]. All procedures were per-
formed in accordance with local institutional guidelines
for animal care and use.
Our procedure typically yields cultures that contain >
90% neurons and < 10% supporting cells. Neuronal pur-
ity was assessed by incubation with rabbit anti-MAP2
polyclonal antibody (Abcam,1:300 dilution) overnight at
4°C, followed by FITC-labeled goat anti-rabbit antibody
(Abcam, 1:1000 dilution) for 1 h at room temperature,
Hoechst 33342 counterstaining (1:10000 dilution) for
10 minutes, and cover slipping in Mowiol mounting
media (Sigma, Germany).
Cultures were maintained at 37°C in a humidified
atmosphere containing 95% air–5% CO2 for 7 days.
Prior to experiments, the medium was replaced by sup-
plemented neurobasal medium after 24 h and changed
every 3 days after.
Treatment with melissa and hypoxia
Balm Oil (B4008 Sigma, Germany) was serially diluted
in serum free medium. Cultures were pretreated with
Melissa for 2 h in normal incubator (95% air i.e., ~21%
O2 –5% CO2 equilibrated to 37°C and 95% humidity) as
normoxia incubator before their transfer in to hypoxia
incubator (90% N2–5% CO2 and 5% O2 equilibrated
to 37°C and 95% humidity) for 24 h [15]. After 24 h
of hypoxia, cultures were removed from the hypoxic
chamber, and were returned to normoxia incubator for
another 4 h reperfusion period until analysis.
MTS/LDH assay
Cell membrane integrity was determined by lactate
dehydrogenase (LDH) using CytoTox-ONETM Homoge-
neous Membrane Integrity Assay according to the
manufacturer’s instructions (Promega, Germany). Two
vials per experiment were treated 2 h with 2μl lysis solu-
tion containing Triton X-100 as positive control. Having
no background from mediums containing Melissa was
assured by reading their absorption with 492nm -
620nm filters which were near zero (Data not shown).
Cell viability was determined by MTS using One Solu-
tion Cell Proliferation Assay according to the manufac-
turer’s instructions (Promega, Germany).
Propidium Iodide (PI) /Hoechst staining and fixation
Cell death was determined by 4 h incubation of cultures
in medium containing 4 μl/ml PI (500μg/ml) (Sigma,
Germany) before fixation. Viable neurons with sufficient
cell membrane integration could pump PI out hence late
apoptotic and necrotic cells could not do that and in this
experiment are presented as PI positive neurons. Cells
were then fixed with 4% formaldehyde for 15 minutes.
Staining was done in darkness to prevent bleaching.
A repeat count of necrotic cells was performed, the cells
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cells were again counted. This provided an index of
the preservation of the PI stain after fixation. Hoechst
33342 0.1 μg/ml (Sigma, Germany) staining was done
for 10 min after fixation in order to normalize PI posi-
tive neurons to the total number of nuclei in the field
which were stained with Hoechst. Cells were visualized
using an Axioskop 2 plus microscope (Carl Zeiss,
Germany) with a 40× phase contrast water immersion
objective, and images captured using an AxioCam HRc
camera controlled by AxioVision software.
Preparation of in vivo ischemia model and drug
administration
All in vivo experiments were performed on male
Sprague–Dawley (250 to 280 g) rats. Before the induc-
tion of transient cerebral ischemia, rats were anaesthe-
tized with chloral-hydrate (350 mg/kg, i.p.) and the body
temperature was maintained at 37±0.5°C throughout the
procedure with the use of a heating pad. A midline inci-
sion was made on the ventral side of the neck to expose
the common carotid arteries. The common carotid arter-
ies were isolated from vagus nerves and clamped with
non-traumatic aneurysm clips [16]. Sham-operated con-
trol rats underwent the same procedure, but without
common carotid artery occlusion. The surgery was
accompanied by a 100% survival rate following common
carotid occlusion. Carotid artery blood flow was reper-
fused by releasing the clips following 20 minutes occlu-
sion. The average duration of operation was about
30 minutes.
Plant material diluted with physiological saline to
obtain a final concentration of 10%. To find out the
most effective dose of M. officinalis we used several dos-
age (50, 100, 200 and 400 mg/kg) of plant material [13].
In order to dose response data, 100 mg/kg of plant ma-
terial was selected (Data not shown). 100 mg/kg Melissa
was gavaged orally using the gavage needle every day for
two weeks before operation as pretreatment and also
continued after ischemia in different reperfusion time
points. Animal groups were three: sham-operated group
also considered as control, vehicle-treated group and
Melissa treated group.
Caspase-3 assay
To recognize the in vivo neuroprotective properties of
Melissa officinalis, we examined caspase-3-like activity
at different time periods after ischemia. Fluorometric
assay kit for caspase-3 activity (BD PharmingenTM) was
used according to manufacturer’s instruction. Rats were
killed, brains were removed and both hippocampi were
rapidly dissected out on ice, were minced with scissors,
and homogenized in ice-cold lysis buffer containing
10 mM Tris–HCl; 10 mM NaH2PO4/NaHPO4 (pH 7.5);130 mM NaCl; 1% TritonR-X-100; 10 mM NaPPi (sod-
ium pyrophosphate). Lysates were centrifuged (14000
rpm, 10 min, 4°C) and the supernatants were taken and
kept in −80°C for further use. Protein concentration
was measured using Bradford protein assay [17]. 100 μg
total protein was incubated for 1 h at 37°C with reaction
buffer [40 mM HEPES (pH 7.5); 20% glycerol; 4 mM
DTT] and the fluorogenic substrate Ac-DEVD-AMC
[N-acetyl-Asp-Glu-Val-Asp-AMC (7-amino-4-methyl-
coumarin)]. The amount of 7-amino-4-methylcoumarin
liberated from the Ac-DEVD-AMC fluorogenic peptide
via the action of caspase-3 was measured on a spectro-
fluorometer with an excitation wavelength of 380 nm
and an emission wavelength of 420 nm.
In situ labeling of DNA fragmentation
TUNEL methodology was used to assess neuronal cell
death in the CA1 (Cornu Ammonis) region of the
hippocampus. Hence it takes 2–3 days for the neuronal
damage of CA1 to become morphologically obvious, cre-
syl violet and TUNEL staining were done at day 5 after
reperfusion. Apoptosis occurring in vivo was assessed by
TUNEL labeling [18]. An in situ cell death detection kit
(Roche, Germany) was used to carry out TUNEL stain-
ing on sections according to the manufacturer's instruc-
tions. Staining was visualized with diaminobenzidine.
Each group contained 7 animals and from each animal 3
sections stained. The number of surviving neurons and
TUNEL-positive cells per millimeter linear length in
the CA1 region [18,19] of the dorsal hippocampus
was counted by an investigator who was blinded to the
experimental conditions.
RT-PCR
Expression of HIF- α, TNF-α and IL1-β are increased
after permanent or transient cerebral ischemia [20-23].
Although anti-inflammatory strategies to attenuate ische-
mic brain injury have been inadequate, we carried out to
examine the gene expression of HIF-1α, IL-1β and TNF-
α after ischemia and anti-inflammatory properties of
Melissa officinalis.
After 20 minutes ischemia and two days reperfusion,
animals were sacrificed by decapitation, brains were
removed rapidly, and hippocampi were dissected quickly,
placed in RNA later RNA Stabilization Reagent (Qiagen,
Germany) over night at 4°C and finally stored at −80°C
until used. Total RNA was extracted using the RNeasy
Mini Spin Columns Collection Tubes (Qiagen, Germany).
Reverse transcription was done using the RT-PCR tech-
nology according to manual instruction (Bioneer, South
Korea). Using specific primer sets (Table 1), aliquots
of cDNA were amplified by a PCR machine (Peqlab,
Germany), with initial denaturation at 94°C for 5 min, fol-
lowed by 30 cycles of denaturation at 94°C for 30 s,





Sequence (5’–3’) accession number
HIF-1α 61 197 F TCAAGTCAGCAACGTGGAAG [GenenBank:024359.1]
R TATCGAGGCTGTGTCGACTG
IL1-b 60 209 F CTGTGACTCGTGGGATGATG [GenenBank:031512.2]
R GGGATTTTGTCGTTGCTTGT
TNF-α 60 209 F CTCCCAGAAAAGCAAGCAAC [GenenBank:012675.3]
R CGAGCAGGAATGAGAAGAGG
GAPDH 59 161 F CATCACCATCTTCCAGGAGCGAGA [GenenBank:017008.3]
R CAGCGGAAGGGGCGGAGA
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30 s, 45 s for extension at 72°C, and a further 5 min final
extension at 72°C on completion of the cycles. Cycle
optimization was performed for each primer set
before PCR. The amplified products were subjected to 1%
(W/V) agarose gel for electrophoresis, stained with eth-
idium bromide, then observed and photographed under
an ultraviolet lamp in a gel imaging system. PCR pro-
duct bands were analyzed with the ImageJ 1.440 software
(National Health Institute, USA), ratios of each target
gene to that of the house-keeping gene GAPDH (glyceral-
dehyde-3-phosphate dehydrogenase) was taken as the
semiquantitative results of the samples.
Determination of Trolox Equivalent Antioxidant
Capacity (TEAC)
Oxidative damage in the ischemic animals was measured
by the level of antioxidant capacity in the tissue homo-
genates. Tissue homogenates TEAC was determined by
its ability to inhibition of peroxidase-mediated formation
of the 2,2'-azino-bis-3-ethylbenzthiozoline-6-sulfonate
(ABTS.+) radical [24]. 50 μL of samples were loaded
onto respective wells on the 96-well microplate. 200 μL
Chromagen (ABTS) (Sigma-Aldrich Inc., USA) was
then added to these wells and the mixture left to react at
25°C for 6 minutes before reading the absorbance at
750 nm using the Bio-Rad Benchmark Plus Microplate
Reader. The capacity of the homogenate antioxidant to
inhibit ABTS oxidation was compared to the water-
soluble vitamin E analogue (trolox) (Sigma-Aldrich Inc.,
USA). The TEAC values were determined from the tro-
lox standard curve. Results were expressed as millimoles
per trolox equivalents per liter of homogenate. TEAC
values were taken as the total antioxidant capacity in the
tissue homogenates samples of the animals.
Assay for thiobarbituric acid reactive substances (TBARS)
Oxidative damage in the ischemic animals was measured
by the level of malondialdehyde (MDA) formed in the
tissue homogenates. MDA levels in hippocampal tissuewere determined according to the method of Ohkawa
et al. [25]. Briefly, the hippocampus was homogenized in
cold 0.1M phosphate buffer (pH 7.4) to make a 10%
homogenate. Then homogenates were centrifuged for
30 min at 3000×g at 4°C. An aliquot of supernatant
was added to a reaction mixture containing 100μl of
8.1% sodium dodecyl sulphate, 750μl of 20% acetic acid
(pH 3.5), 750μl of 0.8% thiobarbituric acid and 300μl dis-
tilled water. Samples were then boiled for 1 h at 95°C
and centrifuged at 4000×g for 10 min. The absorbance
of the supernatant was measured spectrophotometrically
at 532nm and results were expressed as nanomoles of
MDA per mg of protein.
Statistical analysis
The values are expressed as mean ± standard deviation
(SD). The results were computed statistically (Graphpad
Prism 5.0) using t test.
Degrees of significance were assessed by three different
rating values: P<0.05 = *(significant), P<0.01 = ** (highly
significant), and P<0.001 = *** (extremely significant).
For clarity, data in figures are expressed relative to their
respective controls.
Results
Cortical neuronal viability after hypoxia
Almost all types of CNS cells appear to be vulnerable
to hypoxia, including astrocytes, microglia and neurons,
although regional and cellular differences with respect to
exposure time may also be considerable. In a first step,
we aimed to analyze the vulnerability of cortical neurons
to a given hypoxia percent and exposure duration. Cell
viability was assessed by lactate dehydrogenase (LDH)
release in the culture supernatant and metabolic activity
of cells by 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy meth-
oxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) (MTS) in
adherent neurons. As shown in Figure 1 hypoxia induced
a significant increasein LDH activity in the supernatant.
This was paralleled by a decrease in corresponding meta-
bolic activity by MTS assay. After 24 h of 5% hypoxia
Figure 1 MTS/LDH release in normoxic and hypoxic conditions.
Hypoxia induced by 5% oxygen for 24h and followed by 4h
reperfusion in normal condition. Results are given in absorbance
values to control groups which were all the time in normoxia
condition. LDH release is increased and MTS activity is decreased
significantly in hypoxic condition. **P< 0.01, vs. normoxia.
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neurons observed to have declined by approximately 55%
(P< 0.01, vs.normoxia), as indicated by a massive increase
in LDH activity. Metabolic activity was also decreased
around 20% (P< 0.01, vs.normoxia), as shown by MTS ab-
sorbance in Figure 1.
Dose response of cortical neurons to M. Officinalis
In this step, we intended to see the response of cortical
neurons to different concentrations of Melissa. For this
purpose we did a set of LDH and MTS assays in nor-
moxic condition in order to find the suitable dose of
Melissa for further administration in hypoxic condition.
As shown in Figure 2 there was no change in MTS activ-
ity or LDH release in low concentrations (5, 10 andFigure 2 Melissa dose response in normoxia condition. There
is no change in MTS activity or LDH release in low concentrations
(5, 10 and 50 μg/ml) of Melissa in normoxic condition while higher
concentrations (100 and 500 μg/ml) cause significant decrease in
neuronal viability which is seen in MTS reduction and LDH increase.
Results are given as a relation of both MTS and LDH values to their
controls which were in normoxia condition.**P< 0.01, vs. control
or normoxia.50 μg/ml) of Melissa in normoxic condition compared
to control group. But higher concentrations (100 and
500 μg/ml) were seemed to be toxic and caused signifi-
cant decrease in metabolic activity (P< 0.05, vs. control)
(Figure 2).
Protective effects of M. Officinalis during hypoxia in vitro
A 24h hypoxia exposure followed by 4h reperfusion
resulted in an approximately half maximal decline in cell
viability; this protocol was used for all further experi-
ments. To recognize the protective properties of Melissa
on neuronal hypoxia induced death, neurons were trea-
ted with neurobasal medium containing 10 μg/ml con-
centration of Melissa. As shown in Figure 3, PI positive
cortical neurons increased significantly after hypoxia
protocol comparing to normoxia (a and b) and single
dose of Melissa significantly reduced PI positive cell
count comparing to cultures exposed to hypoxia without
any treatment (b and c) (P< 0.05, vs. hypoxia controls).
Caspase-3 activity assay
After 20 minutes ischemia followed byseveral time
pointsof reperfusion, caspase-3like activity in the hippo-
campus was increased significantly (Figure 4) (P< 0.01,
vs. controls animals).
At day 3 caspase-3 activity as seen in Figure 4 was at
highest level. On the basis of the above mentioned result
and also a recent similar study [26], we assessed the ef-
fect of in vivo treatment with Melissa officinalis on the
caspase-3like protease activity at day 3of reperfusion.
Treatment with 100 mg/kg of Melissa oilattenuated the
increased caspase-3 like protease activity significantly
(P< 0.05, vs.ischemia group) (Figure 4).
In situ labeling of DNA fragmentation
TUNEL staining revealed that many TUNEL-positive
neurons were present in the hippocampal CA1 region of
ischemic rats (Figure 5b). Few TUNEL-positive cells
were found in the CA1 region of sham operated rats
(Figure 5a). The number of TUNEL-positive cells was
reduced by treatment with plant material (Figure 5c).
Cresyl violet staining revealed extensive neuronal loss
in the CA1 region of ischemic rats (Figure 5e). No cell
damage was evident by the cresyl violet staining in the
CA1 region of sham-operated rats (Figure 5d). Hippo-
campal neuronal damage was decreased by treatment
with 100mg/kg Melissa administration (Figure 5f ).
RT-PCR
Expression of HIF- α, TNF-αand IL1-β are increased
after permanent or transient cerebral ischemia [21-23].
We further examined the expression of HIF-1α, TNF-α
and IL1-β after ischemia and when treated with Melissa
in the ischemic rat brain. On the basis of similar studies
Figure 3 PI positive neurons in normoxia (a), hypoxia (b) and 10 μg/ml treatment of melissa (c). Total number of PI positive neurons is
higher than hypoxic groupafter Melissa treatment (b and c). PI positive neurons (red) were counted and normalized to all cells counterstained
with Hoechst (blue).*P< 0.05, vs. control.
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expression of HIF- α, TNF-α and IL1-β were measured.
As shown in Figure 6, mRNA expressions of HIF-1α,
TNF-α and IL1-β were up-regulated after ischemia/
reperfusion injury (p < 0.01). Melissa (100 mg/kg) treat-
ment suppressed the expression of HIF-1α in the ischemic
hippocampus (P<0.05) while TNF-α and IL1- β expression
have not been decreased significantly (Figure 6).Lipid peroxidation and antioxidant capacity
In ischemic animals, on the basis of a recent similar study,
MDA level and antioxidant status in hippocampus mea-
sured at day 2of reperfusion [18]. MDA level increased
after 2 days of reperfusion. In balm oil treated (100 mg/kg)
ischemic animals MDA level was significantly lower than
sham operated animals (P< 0.01) (Figure 7).
The antioxidant status was assessed by studying the
level of TEAC in the tissue homogenates. A loweredFigure 4 Caspase-3-like activity. Left: Temporal profiles of caspase-3-like
in % of control group absorbance value. Significant increase in caspase-3 a
control animals(n=8). Right: Treatment with 100 mg/kg of Melissa officinalis
ischemia group (n=11).antioxidant defense system in ischemic animals compared
to the sham operated animals is noted. At day 2 of reper-
fusion TEAC concentrations in tissue homogenates of
ischemic animals were lower than sham operated animals.
In balm oil treated (100 mg/kg) ischemic animals the level
of TEAC was significantly higher than ischemic animals
(p < 0.05) (Figure 7).Discussion
Increasing evidence has indicated that production of free
radicals after cerebral ischemia and reperfusion, caused
oxidative stress which is involved in ischemic brain dam-
age [29]. During ischemia and especially reperfusion, free
radicals are expected to attack lipids and proteins of the
cell membrane and DNA [30]. Novel therapeutic neuro-
protective strategies support the applications of ROS
scavengers and induction of endogenous antioxidants,
such as natural antioxidants, for example plant derivedactivity in the hippocampus after transient ischemia. Results are given
ctivity is observed after 48h and 72h reperfusion. ***p < 0.001, vs.
attenuated the increased caspase-3 like protease activity. *P< 0.05, vs.
Figure 5 Micrographs of TUNEL-positive cells and cresyl-violet stained cells. Representative micrographs of TUNEL-positive cells
(dark brown) (a–c) and cresyl-violet stained cells (d–f) in the hippocampal CA1 region from sham (a and d); ischemic (b and e); Melissa-treated
animals (c and f) at 5 days of reperfusion. Scale bar: 50μm. Graph shows the comparison of apoptotic (TUNEL-positive) and surviving (Nissel
positive) neurons between groups. *p < 0.05, **p < 0.01 compared with ischemia group (n=7).
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generative diseases [18,31,32]. It is known that some
compounds of Melissa officinalis have antioxidant activ-
ity which is due to its free Radical Scavenging Capacity
(RSC) [33]. Antioxidant activity of Melissa has previ-
ously been reported in different studies [8,33-35]. In
addition it is reported that this plant has protective
effect on hydrogen peroxide induced toxicity in PC12
cells which have some characteristics of neurons [7], but
the protective effects in primary culture of neurons after
hypoxic stress have never been reported. In this study,
24 h exposure of primary cortical neurons to 5% hypoxia
followed by 4 h reperfusion reduced both cell viability
and metabolic activity to around 55% and 20%, respect-
ively. This could be considered as an approval on hyp-
oxia system. Hoechst/PI staining of neurons showed that
10 μg/ml concentration of Melissa could significantly
reduce cell death. Although, analysis of dose response
results showed that high doses (100–500 μg/ml) could
worsen the condition with500 μg/ml dose as half max-
imal inhibitory concentration (IC50) of Melissa. These
results suggest that some concentrations of Melissa have
protective activities in neurons and may keep them safe
from oxidative stress. In vitro results lead us to postulate
the hypothesis that Melissa could have some protectiveeffects on neurons in the brain. Therefore, we examined
its effects in ischemic model of brain injury as in vivo
model. Investigations showed that after induction of
ischemia, Caspase-3 activity in hippocampus significantly
increased, and there were many TUNEL positive neurons
in CA1 area. TUNEL is a common method for detecting
DNA fragmentation that results from apoptotic signal-
ling cascades. The assay relies on the presence of nicks
in the DNA which can be identified by terminal deoxy-
nucleotidyl transferase or TdT, an enzyme that will cata-
lyse the addition of dUTPs that are secondarily labelled
with a marker. It may also label cells that have suffered
severe DNA damage.
Mechanisms leading to DNA fragmentation following
ischemia may not be clear but a specific DNase, caspase-
activated DNase (CAD) that cleaves chromosomal DNA
appears to be an important enzyme in apoptotic cell
death. CAD is generally found as a complex with ICAD
(inhibitor of CAD) which serves to limit its DNase activ-
ity. After initiation of apoptosis signals, caspases, in par-
ticular caspase-3, cleave ICAD to dissociate CAD from
ICAD, thereby allowing CAD to cleave chromosomal
DNA [36]. So we investigate both caspase-3 activity and
DNA fragmentation. This could suggest that Melissa
provided neuroprotection against cerebral I/R injury in
Figure 6 RT-PCR analysis of HIF-1α, TNF-α and IL-1β gene expression in the hippocampus of ischemic rats after ischemia. 100 mg/kg
treatment of Melissa significantly suppressed the expression of HIF-1α in the ischemic hippocampus (P<0.05) while TNF-α and IL1-β expression
have not been significantly decrease (n=8).
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in vitro study and this is the first time that shows pro-
tective activity for Melissa officinalis after brain ischemia.
In present study, the increased MDA and decreased
antioxidant defense system in the hippocampus of theFigure 7 Lipid Peroxidation and Antioxidant Capacity. Left: Compariso
sham operated, ischemic and Melissa officinalis treated ischemic animals. Tr
levels in the hippocampus (**p < 0.01) and attenuates decrease of antioxidischemic group as compared to the sham group sug-
gests a state of enhanced oxidative stress in ischemia–
reperfusion injury. Apoptotic cell death occurs in
response to various stimuli including oxidative stress
[37]. The brain is very vulnerable to oxidative stress duen of the level of MDA (left) and TEAC (right) inthe hippocampus of
eatment with 100 mg/kg of Melissa decreased the elevated MDA
ant status of ischemic animals (*p < 0.05) (n = 8 each).
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which is particularly susceptible to ROS damage [38].
During ischemia, superoxide anions and hydrogen
peroxide form and cannot be readily scavenged. Lipid
peroxidation (LPO) is one of the important markers of
oxidative damage in the ischemic cascade as PUFA con-
stitutes a major component of brain, which results in
the formation of lipid peroxides, and may affect a variety
of cellular functions involving proteins namely: recep-
tors, signal transduction mechanisms, transport systems
and enzymes [39]. Treatment of ischemic rats with
Melissa significantly inhibited MDA level and attenuated
decrease of antioxidant capacity in the hippocampus.
It is well documented that attenuating oxidative stress
is important in evolving neuroprotective strategies for
enhanced neuronal survival after cerebral ischemia [18].
We suggest that some components of plant material that
have antioxidative properties can attenuate oxidative
damage induced by ischemic brain injury.
Ischemic brain injury induced increase in HIF-1α,
IL-1β and TNF-α mRNA level, this can represent the
inflammatory response of neuronal or glial cells suffering
from the ischemic insult. It is demonstrated that expres-
sion of HIF-1α and HIF-1β mRNA in rat and mouse has
been up-regulated in ischemic brain injury [23]. In this
study, showed that the elevation of active caspase-3
expression occurred as well as HIF-1α expression after
ischemic injury, and these events could be significantly
suppressed by treatment with Balm oil. Hypoxia can
cause HIF-1α to bind with p53 in order to stabilize it,
and also activates the expression of various genes,
including bax. In this study, plant material can down-
regulate the transcription of HIF-1α during hippocampal
ischemia and inhibit caspase-3 activation. Proinflam-
matory and immunomodulatory cytokines like TNF-α,
IL-1β and IL-6 mRNA level increases after focal ischemia
[22], implicating that these cytokines can develop ische-
mic brain injury. Gene expression of TNF-α and IL-1β,
after cerebral ischemia is up-regulated. Treatment of is-
chemic animals with Melissa did not effectively inhibit
mRNA expression of TNF-α and IL-1β, indicating that
the inhibition of TNF-α and IL-1β might not be the neu-
roprotective mechanism for plant materialin ischemic
brain injury.
Conclusions
In conclusion, results implicate that Melissa officinalis
has shown protective effect on ischemic damage
mediated by the inhibition of HIF-1α and oxidative
stress, followed by the inhibition of apoptosis.
These results propose the potential use of Melissa
officinalis or its constituents for central nervous system
diseases and as a neuroprotective agent to prevent disor-
ders involved with oxidative stress. Experiments arenecessary to identify which of the plant components are
responsible for these activities.
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